Cargando…

Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism

BACKGROUND: Fibroblast growth factor 23 (FGF23) is a key regulator of urine phosphate excretion. The aim of the study was to investigate the perioperative (intraoperative and postoperative) changes of plasma intact and C-terminal FGF23 (iFGF23, cFGF23) concentrations in patients with primary hyperpa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fořtová, Magdaléna, Hanousková, Lenka, Valkus, Martin, Čepová, Jana, Průša, Richard, Kotaška, Karel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859952/ https://www.ncbi.nlm.nih.gov/pubmed/34860179 http://dx.doi.org/10.1530/EC-21-0430

Ejemplares similares

Diagnostic benefits of mindin as a prostate cancer biomarker: Dijagnostičke prednosti mindina kao biomarkera raka prostate
por: Hanousková, Lenka, et al.
Publicado: (2020)

Parathyroid Hormone Regulates Circulating Levels of Sclerostin and FGF23 in a Primary Hyperparathyroidism Model
por: Nagata, Yuki, et al.
Publicado: (2022)

Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism
por: Sykała, Monika, et al.
Publicado: (2021)

LC–MS/MS quantitative analysis of phylloquinone, menaquinone-4 and menaquinone-7 in the human serum of a healthy population
por: Dunovska, Katerina, et al.
Publicado: (2019)

Surgery for primary hyperparathyroidism
por: Neves, Murilo Catafesta das, et al.
Publicado: (2022)

Evaluation of Serum Level of FGF23 and 1,25(OH)(2)D(3) in Primary Hyperparathyroidism Patients Before and After Parathyroidectomy
por: Hassani, Solmaz, et al.
Publicado: (2020)

Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level
por: Chertok Shacham, Elena, et al.
Publicado: (2023)

SUN-496 A Perioperative Risk For Exacerbation of Hypercalcemia in Primary Hyperparathyroidism
por: Tezuka, Yuta, et al.
Publicado: (2019)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)

Correlation of perioperative biochemical variables with single adenoma weight in patients with primary hyperparathyroidism
por: Papadakis, Marios, et al.
Publicado: (2020)

Cholecalciferol supplementation effectively improved tertiary hyperparathyroidism, FGF23 resistance and lowered coronary calcification score: a prospective study
por: Hu, Shu-Meng, et al.
Publicado: (2022)

OR23-06 Long Term Outcomes Of Parathyroid Autografts In Primary Hyperparathyroidism
por: Chuki, Elias, et al.
Publicado: (2023)

Evaluation of diagnostic efficacy for localization of parathyroid adenoma in patients with primary hyperparathyroidism undergoing repeat surgery
por: Hendricks, Anne, et al.
Publicado: (2021)

FGF-23 in bone biology
por: Wesseling-Perry, Katherine
Publicado: (2009)

FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019)

Pleiotropic Actions of FGF23
por: Erben, Reinhold G.
Publicado: (2017)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)

Dementia Improvement after Primary Hyperparathyroidism Surgery
por: Voci, Claudio
Publicado: (2020)

Monocentric experience of primary hyperparathyroidism surgery in Algeria
por: Nouikes Zitouni, Souad
Publicado: (2021)

Abstract 23: Primary hyperparathyroidism masking hypercalcemia of malignancy: A case report
por: Alekya, V, et al.
Publicado: (2022)

The Changing Face of Primary Hyperparathyroidism
por: Parmar, Girish, et al.
Publicado: (2018)

Preoperative Thyroid Ultrasound Is Indicated in Patients Undergoing Parathyroidectomy for Primary Hyperparathyroidism
por: Arciero, Cletus A., et al.
Publicado: (2011)

Primary Hyperparathyroidism
por: Bandeira, Leonardo, et al.
Publicado: (2016)

Primary hyperparathyroidism
por: Wang, Ao, et al.
Publicado: (2019)

Primary Hyperparathyroidism in Pregnancy: Literature Review of the Diagnosis and Management
por: Ali, Dalal S., et al.
Publicado: (2021)

Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism
por: Choi, Hye Ryeon, et al.
Publicado: (2022)

FGF23 Producing Mesenchymal Tumor
por: Papierska, Lucyna, et al.
Publicado: (2014)

FGF23 as a calciotropic hormone
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2015)

FGF23 in Acute and Chronic Illness
por: Schnedl, Christian, et al.
Publicado: (2015)

Role of FGF23 in Pediatric Hypercalciuria
por: Moreira Guimarães Penido, Maria Goretti, et al.
Publicado: (2017)

Paracrine Effects of FGF23 on the Heart
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

FGF23, Hypophosphatemia, and Emerging Treatments
por: Imel, Erik A, et al.
Publicado: (2019)

FGF23 and Vitamin D Metabolism
por: Latic, Nejla, et al.
Publicado: (2021)

MicroRNAs as Potential Regulators of Glutathione Peroxidases Expression and Their Role in Obesity and Related Pathologies
por: Matoušková, Petra, et al.
Publicado: (2018)

Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery?
por: Aojula, Nivaran, et al.
Publicado: (2021)

Perioperative Optimization of Patients Undergoing Bariatric Surgery
por: Owers, C. E., et al.
Publicado: (2012)

Lactic acid induces fibroblast growth factor 23 (FGF23) production in UMR106 osteoblast-like cells
por: Alber, Jana, et al.
Publicado: (2021)

Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium
por: Schini, Marian, et al.
Publicado: (2020)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_stan497qvkiqgdp7nlgdbipcc2